1873373-33-1Relevant articles and documents
Discovery of Potent, Selective, and Peripherally Restricted Pan-Trk Kinase Inhibitors for the Treatment of Pain
Bagal, Sharan K.,Andrews, Mark,Bechle, Bruce M.,Bian, Jianwei,Bilsland, James,Blakemore, David C.,Braganza, John F.,Bungay, Peter J.,Corbett, Matthew S.,Cronin, Ciaran N.,Cui, Jingrong Jean,Dias, Rebecca,Flanagan, Neil J.,Greasley, Samantha E.,Grimley, Rachel,James, Kim,Johnson, Eric,Kitching, Linda,Kraus, Michelle L.,McAlpine, Indrawan,Nagata, Asako,Ninkovic, Sacha,Omoto, Kiyoyuki,Scales, Stephanie,Skerratt, Sarah E.,Sun, Jianmin,Tran-Dubé, Michelle,Waldron, Gareth J.,Wang, Fen,Warmus, Joseph S.
, p. 6779 - 6800 (2018/07/05)
Hormones of the neurotrophin family, nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT3), and neurotrophin 4 (NT4), are known to activate the family of Tropomyosin receptor kinases (TrkA, TrkB, and TrkC). Moreover, in
